公开(公告)号：EP3027063B1

公开(公告)日：2018-11-21

申请号：EP14747618.8

申请日：2014-07-31

Applicant: Bunge Loders Croklaan B.V.

Inventor： GAMBELLI, Luisa ,  HAPPE, Randolph ,  BANNI, Sebastiano

IPC: A23L33/10 ,  A23L33/00 ,  A61K31/20 ,  A61K31/23 ,  A61P25/28

CPC classification number: A61K31/231 ,  A23L33/12 ,  A23L33/15 ,  A23L33/16 ,  A23L33/17 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A61K31/20 ,  A61K31/201 ,  A61K31/202 ,  A61K31/23 ,  A23V2200/322 ,  A23V2250/186

Abstract: A composition for use in developing and/or improving brain function comprises a glyceride having a palmitoyl group at the 2-position wherein at least 40% by weight of the palmitic acid content of the composition is present as palmitoyl groups bonded at the 2-position of a glyceride.

公开(公告)号：EP2832346B1

公开(公告)日：2018-10-10

申请号：EP13769727.2

申请日：2013-02-06

Applicant: FUJIFILM Corporation

Inventor： MURAGUCHI, Taichi

IPC: A61K8/67 ,  A61K8/06 ,  A61K8/37 ,  A61K8/55 ,  A61K47/14 ,  A61K47/22 ,  A61K47/24 ,  A61Q19/00 ,  A61K8/39 ,  A61K8/00 ,  A61K8/02 ,  A61K8/04 ,  A61K9/00 ,  A23L33/15

CPC classification number: A61K47/24 ,  A23L33/15 ,  A23V2002/00 ,  A23V2200/00 ,  A61K8/0241 ,  A61K8/044 ,  A61K8/39 ,  A61K8/553 ,  A61K8/671 ,  A61K8/678 ,  A61K9/0014 ,  A61K47/14 ,  A61K47/22 ,  A61K2800/262 ,  A61K2800/413 ,  A61K2800/652 ,  A61Q19/00 ,  A23V2250/712

Abstract: An aqueous dispersion composition including dispersed particles that include: a naturally occurring type vitamin E compound, retinyl palmitate, an oil agent having an calculated octanol-water partition coefficient (cLogPow) of from 0 to 12, and a phospholipid.

公开(公告)号：EP3329787A4

公开(公告)日：2018-06-06

申请号：EP15906744

申请日：2015-10-19

Applicant: FAMENITY CO LTD

Inventor： LEE JI WON ,  KIM SUNG SU

IPC: A23L33/10 ,  A23L33/00 ,  A23L33/105 ,  A61K36/28 ,  A61K36/53 ,  A61P15/12 ,  B01D11/02

CPC classification number: A23L19/00 ,  A23L33/10 ,  A23L33/105 ,  A23L33/40 ,  A23V2200/00 ,  A61K36/28 ,  A61K36/53 ,  B01D11/02 ,  A23V2200/30 ,  A23V2200/31 ,  A23V2250/21 ,  A23V2300/14

Abstract: The present invention relates to a food composition for improvement and prevention of estrogen deficiency, the composition containing a thistle extract or a thistle and thyme complex extract as an active ingredient. The present invention has advantages of alleviating estrogen deficiency in climacteric women and improving symptoms caused by estrogen deficiency, such as facial flushing, sweating, fatigue, anxiety, depression, memory impairment, insomnia, increased blood cholesterol, weight gain, and reduced bone density.

公开(公告)号：EP2928323B1

公开(公告)日：2018-01-03

申请号：EP13802293.4

申请日：2013-11-27

Applicant: Unilever PLC ,  Unilever N.V.

Inventor： BERRY, Mark, John ,  FOWLER, Mark, Ian ,  HEATH, Alan, David

IPC: A23L33/105 ,  A61K31/7048 ,  A61K31/7034 ,  A23L33/10 ,  A23L2/52 ,  A61K31/05

CPC classification number: A61K31/7048 ,  A23L2/52 ,  A23L33/10 ,  A23L33/105 ,  A23V2002/00 ,  A23V2200/00 ,  A61K31/05 ,  A61K31/7034 ,  A61K2300/00 ,  A23V2200/328 ,  A23V2250/2116

Abstract: Foods or meals high in available carbohydrate such as sucrose or starch increase postprandial blood glucose concentrations. Repeated high post-prandial plasma glucose “spikes” are associated with an increased risk of developing type II diabetes. Unregulated glycemic excursions are undesirable, and any reduction or “blunting” of the post-prandial glucose concentration in blood is potentially beneficial. This invention relates to an edible composition for delay of intestinal glucose uptake through synergistic inhibition of both active sodium glucose co-transporter 1 (SGLT1) and passive glucose transporter 2 (GLUT2) leading to flattening or blunting of the post-prandial glucose peak. In a first aspect of the invention, an edible composition is provided, in the form of a single serving of one or more unit dosages, wherein the edible composition comprises 20-2000, preferably 30-1000, most preferably 40-500 mg a 3,5-dihydroxy-trans-stilbene and 10-2000, preferably 20-1000, most preferably 40-500 mg flavonoid mono-glucoside or dihydrochalcone monoglucoside.

公开(公告)号：EP3086666B1

公开(公告)日：2017-10-11

申请号：EP14818906.1

申请日：2014-12-09

Applicant: Nestec S.A.

Inventor： GALAFFU, Nicola ,  HABEYCH NARVAEZ, Edwin Alberto ,  MERINAT, Sylvie Joëlle

IPC: A23L33/10 ,  A23L29/00 ,  A23L19/00 ,  A23L2/02 ,  A23L2/39

CPC classification number: A23L2/52 ,  A23C9/123 ,  A23L2/02 ,  A23L2/39 ,  A23L19/09 ,  A23L29/03 ,  A23L33/105 ,  A23L33/165 ,  A23V2002/00 ,  A23V2200/00 ,  A23V2200/02 ,  A23V2200/044 ,  A23V2200/214 ,  A23V2200/30

公开(公告)号：EP3214951A1

公开(公告)日：2017-09-13

申请号：EP15784863.1

申请日：2015-10-08

Applicant: MJN U.S. Holdings, LLC

Inventor： CHICHLOWSKI, Maciej ,  BERG, Brian ,  JOUNI, Zeina ,  WITTKE, Anja ,  WAWORUNTU, Rosaline

IPC: A23L33/00 ,  A23L33/10 ,  A23L33/115 ,  A23L33/17

CPC classification number: A23L33/21 ,  A23L33/19 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A23V2200/32 ,  A23V2200/3202 ,  A23V2200/322 ,  A23V2250/284 ,  A23V2250/54248

Abstract: Provided is a composition and method for modulating serotonergic receptor expression, reducing anxiety-like behavior and stress-induced inflammatory response in a pediatric subject, the method including administering to the pediatric subject a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides. Further provided is a method for reducing constipation in a pediatric subject by providing a nutritional composition including lactoferrin from a non-human source and a prebiotic composition including polydextrose and/or galactooligosaccharides.

Abstract translation: 本发明提供调节5-羟色胺能受体表达，减少儿科患者的焦虑样行为和应激诱导的炎症反应的组合物和方法，所述方法包括向儿科患者施用营养组合物，所述营养组合物包含来自非人源的乳铁蛋白和益生元 包括聚右旋糖和/或低聚半乳糖的组合物。 进一步提供了通过提供包含来自非人来源的乳铁蛋白和包含聚葡萄糖和/或低聚半乳糖的益生元组合物的营养组合物来减少儿科受试者便秘的方法。

公开(公告)号：EP2768323B1

公开(公告)日：2017-06-14

申请号：EP12778093.0

申请日：2012-10-19

Applicant: Nestec S.A.

Inventor： POUTEAU, Etienne ,  BOVETTO, Lionel Jean René ,  MACE, Catherine

IPC: A23L33/19 ,  A61K35/20 ,  A23L33/10 ,  A61P3/10

CPC classification number: A23J1/205 ,  A23C21/00 ,  A23L2/52 ,  A23L2/66 ,  A23L33/19 ,  A23L33/30 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A61K35/20 ,  A23V2200/332 ,  A23V2250/54252

Abstract: The present invention relates to whey protein micelles for use in the treatment and/or prevention of a disorder linked to an increase in plasma postprandial insulin and/or plasma postprandial glucagon concentration in a subject. The invention relates also to a non-therapeutic use of whey protein micelles to decrease plasma postprandial insulin and/or glucagon concentration in healthy subjects.

Abstract translation: 本发明涉及用于治疗和/或预防与对象中血浆餐后胰岛素和/或血浆餐后胰高血糖素浓度增加有关的病症的乳清蛋白胶束。 本发明还涉及乳清蛋白胶束在健康受试者中降低血浆餐后胰岛素和/或胰高血糖素浓度的非治疗用途。

公开(公告)号：EP2822402B1

公开(公告)日：2017-05-10

申请号：EP13711144.9

申请日：2013-03-08

Applicant: N.V. Nutricia

Inventor： LYNCH, Andrew Sean ,  ANDERS, Simon David

IPC: A61P3/00 ,  A61K31/198 ,  A61K31/723 ,  A61K31/732 ,  A61K31/736 ,  A23L2/02 ,  A23L2/66 ,  A61K33/06 ,  A23L33/00 ,  A23L33/16 ,  A23L33/175

CPC classification number: A23L1/296 ,  A23L2/02 ,  A23L2/66 ,  A23L33/16 ,  A23L33/175 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A23V2200/30 ,  A23V2200/32 ,  A23V2250/00 ,  A23V2250/032 ,  A23V2250/06 ,  A23V2250/1578 ,  A23V2250/161 ,  A23V2250/506 ,  A23V2250/5072 ,  A23V2250/5086 ,  A23V2250/70 ,  A61K31/198 ,  A61K31/723 ,  A61K31/736 ,  A61K33/06 ,  A61K2300/00

Abstract: The invention relates to a liquid or gelled pasteurized or sterilized composition comprising free amino acids, calcium, a digestible carbohydrate, and preferably an indigestible carbohydrate, wherein the free amino acids are present in a concentration between 5 and 30 g/100 ml, and the dry weight of the total composition is at least 40 g/100 ml, and preferably lower than 60 g/100 ml. The composition may in particular be used in the treatment of a human suffering from a disorder selected from the group consisting of phenylketonuria, homocystinuria, maple syrup urine disease, tyrosinaemia, propionic acidaemia, methylmalonic acidaemia, isovaleric acidaemia, urea cycle disorders and glutaric aciduria.

Abstract translation: 本发明涉及包含游离氨基酸，钙，可消化的碳水化合物，优选不消化的碳水化合物的液体或凝胶巴氏杀菌或灭菌的组合物，其中游离氨基酸以5至30g / 100ml的浓度存在，且 总组合物的干重至少为40克/ 100毫升，优选低于60克/ 100毫升。 该组合物可特别用于治疗患有选自苯丙酮尿症，高胱氨酸尿症，枫糖尿病，酪氨酸血症，丙酸血症，甲基丙二酸血症，异戊酸血症，尿素循环障碍和戊二酸尿症的病症的人。

公开(公告)号：EP2768324B1

公开(公告)日：2017-02-01

申请号：EP12786858.6

申请日：2012-10-19

Applicant: Nestec S.A.

Inventor： POUTEAU, Etienne ,  ACHESON, Kevin John ,  BOVETTO, Lionel Jean René ,  BREUILLE, Denis

IPC: A61K35/20 ,  A61P3/04 ,  A23L33/19 ,  A23L33/10

CPC classification number: A23L1/3056 ,  A23C21/00 ,  A23K20/147 ,  A23L33/19 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A61K35/20 ,  A61K38/018 ,  A23V2200/332 ,  A23V2250/54252

公开(公告)号：EP3120715A1

公开(公告)日：2017-01-25

申请号：EP16174421.4

申请日：2013-01-09

Applicant: N.V. Nutricia

Inventor： VAN ELBURG, Roelof Matthijs ,  BOEHM, Günther

IPC: A23L33/175 ,  A61K31/198

CPC classification number: A23L33/175 ,  A23L33/40 ,  A23V2002/00 ,  A23V2200/00 ,  A61K31/198 ,  A61K31/702 ,  A61K38/05 ,  A61K38/06 ,  A23V2200/322 ,  A23V2250/062 ,  A61K2300/00

Abstract: The present invention relates to the use of nutritional compositions enriched in glutamine to improve structural brain development in preterm and/or low birth weight infants.

Abstract translation: 本发明涉及富含谷氨酰胺的营养组合物用于改善早产儿和/或低出生体重婴儿结构性脑发育的用途。